Welcome to our dedicated page for TransUnion SEC filings (Ticker: TRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransUnion filings document the public-company disclosures of a credit reporting, consumer information, fraud detection, marketing, and analytics provider. Recent Form 8-K reports cover quarterly operating results, Regulation FD presentations, Investor Day materials, and management discussions of the company’s proprietary data foundation, OneTru technology platform, and Credit, Marketing, Fraud, and Consumer Solutions.
The company’s SEC record also includes proxy materials for annual meeting matters, director elections, board committee assignments, executive compensation, and governance practices. Other filings document material agreements, credit facility amendments, revolving credit commitments, guarantees, collateral arrangements, capital structure, and board composition changes.
Jennifer A. Williams, SVP and Chief Accounting Officer of TransUnion (TRU), reported two transactions. On 08/25/2025 the company withheld 102 shares at $89.46 to satisfy tax withholding upon the vesting of restricted stock units granted September 1, 2022. On 08/26/2025 she sold 245 shares at $89.22 under a Rule 10b5-1 trading plan. Following these reported transactions she beneficially owned 6,761 shares directly. The filing is signed by a power of attorney on behalf of the reporting person on 08/27/2025.
On 08/25/2025 TransUnion officer Todd C. Skinner reported the disposition of 1,207 shares of common stock at a price of $89.46 per share. The filing states the shares were withheld by the company to satisfy tax withholding obligations from the vesting of restricted stock units originally granted on February 25, 2022. After the transaction, the reporting person beneficially owned 37,764.0189 shares, which includes 201.0189 shares acquired under the employee stock purchase plan since the last report. The form was signed by power of attorney on 08/26/2025.
TransUnion insider filing: Heather J. Russell, Executive Vice President and Chief Legal Officer, reported a transaction on 08/25/2025 disposing of 990 shares of TransUnion common stock at $89.46 per share. The filing states these shares were withheld by the company to satisfy tax withholding related to the vesting of restricted stock units granted on February 25, 2022. After this withholding, Ms. Russell beneficially owns 31,606 shares, held directly. The Form 4 was signed by a power of attorney on 08/26/2025.
Insider sale recorded by TransUnion officer Steven M. Chaouki: the Form 4 shows that on 08/25/2025 Mr. Chaouki had 1,650 shares of TransUnion common stock disposed of at an average price of $89.46 per share. The filing explains these shares were withheld by the company to satisfy tax liabilities arising from the vesting of restricted stock units granted on February 25, 2022. After the withholding, the reporting person beneficially owns 71,743 shares. The Form 4 was signed on 08/26/2025 by an attorney-in-fact.
Insider stock withholding to cover taxes after RSU vesting. TransUnion executive Venkat Achanta had 1,356 shares of common stock withheld at an average price of $89.46 per share to satisfy tax liabilities arising from restricted stock units that vested. After this withholding, Mr. Achanta beneficially owns 102,939 shares of TransUnion common stock. The transaction is reported as a disposition (withholding) tied to RSUs originally granted on February 25, 2022, and reflects a routine internal tax settlement rather than an open-market sale.
TransUnion insider sale to satisfy tax withholding tied to vested RSUs. Executive Todd M. Cello, EVP & CFO, reported disposition of 1,938 shares of TransUnion common stock on 08/25/2025 at a reported price of $89.46 per share. After the transaction, Mr. Cello beneficially owned 97,094 shares.
The filing states the sale reflects shares withheld by the company to pay taxes arising from the vesting of restricted stock units originally granted on February 25, 2022. The Form 4 was submitted via power of attorney on 08/26/2025.
TransUnion insider transaction by CEO/Director Christopher A. Cartwright. The Form 4 reports a transaction on 08/25/2025 where 6,932 shares of TransUnion common stock were disposed of at $89.46 per share. After the reported transaction, Mr. Cartwright beneficially owned 417,745 shares directly and 5,691 shares indirectly through a limited liability company. The filing explains the disposition reflects shares withheld by the company to satisfy tax liability arising from restricted stock units granted on February 25, 2022. The form was signed by a power of attorney on 08/26/2025.
Chaouki Steven M, an officer of TransUnion (TRU) serving as President, US Markets, reported a sale of 1,000 shares of TransUnion common stock on 08/08/2025 at a reported price of $91.21 per share. After this transaction the reporting person beneficially owned 73,393 shares in a direct ownership form.
The Form 4 specifies the sales were executed pursuant to a Rule 10b5-1 trading plan, indicating the transactions were preplanned under that compliance framework. The filing is limited to this single non-derivative sale and the resulting direct shareholding disclosed on the form.
TransUnion (TRU) – Form 144 insider sale notice
Insider Steven Chaouki has filed to sell up to 1,000 common shares of TransUnion, worth an estimated $91,210 (≈$91.21 per share). The transaction will be executed through Fidelity Brokerage Services on or about 08 Aug 2025 on the NYSE. The shares represent only 0.0005 % of the 194.8 million shares outstanding, making the sale immaterial at the company level.
The stock was acquired on 25 Feb 2025 via restricted-stock vesting as compensation. Chaouki has already sold 2,000 shares during the prior three months for total proceeds of $172,050, bringing potential cumulative sales to 3,000 shares (~$263 k). The filer certifies that no non-public, material adverse information is known. No 10b5-1 plan date is disclosed, and the filing contains no other operational or financial updates.